PLSE

Pulse Biosciences Inc (DE) (PLSE)

About Pulse Biosciences Inc (DE) (PLSE)

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Details

Daily high
$21.47
Daily low
$20.36
Price at open
$21.38
52 Week High
$22.69
52 Week Low
$6.60
Market cap
1.3B
Dividend yield
0.00%
Volume
207,426
Avg. volume
207,014
P/E ratio
-26.51

Pulse Biosciences Inc (DE) News

Details

Daily high
$21.47
Daily low
$20.36
Price at open
$21.38
52 Week High
$22.69
52 Week Low
$6.60
Market cap
1.3B
Dividend yield
0.00%
Volume
207,426
Avg. volume
207,014
P/E ratio
-26.51